A critical advance in cancer research is arising with the use of mini-antibodies to re-engage damaged p53. This essential cancer inhibitor protein is frequently inactivated in various types of cancer, resulting https://7bookmarks.com/story21803585/vhh-fragments-reactivate-tumor-suppressor-p53-new-new-hope-for-malignant-management